To get the best possible experience using our website we recommend that you upgrade to another web browser. Outdated browsers don't follow the latest web standards, are full of bugs, don't offer the new browser features and may have security issues and malware. These browsers are normally no longer supported.
Please make use of one of the following links to upgrade you browser and website surfing experience. They are free to upgrade and you will have the advantage of having the new browser keep its self up to date as well as the latest features.
South Africa is one of the 22 countries globally, that is designated by the WHO as a “TB hot spot” country. Six countries account for 60% of the total TB cases, with India leading the count, followed by Indonesia, China, Nigeria, Pakistan and South Africa. The number of TB cases reported in South Africa was relatively stable between 1980 and 1989. Fuelled by the rise in HIV prevalence, the number of TB cases increased from 68,027 TB cases (187/100,000) in 1989 to 188,695 TB cases (424/100,000) in 2001, an increase of 276% and a prevalence of 768 per 100 000 a decade later. The total cases notified in 2016 were 244,053 (new and relapse cases) with a TB/HIV incidence of 461/100,000.
In 2016 an estimated 1.3 million people who were HIV negative died of TB. In addition there were 374,000 deaths resulting from TB disease among people who were HIV positive. So there were a total of 1,674,000 TB related deaths.
An estimated 250,000 children died of TB in 2016 including children with HIV associated TB.
People who have both TB and HIV when they die, are internationally classified as having died from HIV. Forty percent of HIV deaths were due to TB.
In 2016 only 6.3 million cases of TB were reported, but there were globally an estimated 10.4 new cases of TB. So where are these “missing” four million? How can they be found and provided with treatment?
A serious complication to the Tuberculosis epidemic in South and southern Africa has been the emergence of multi-drug resistant (MDR) strains or extensively drug resistant TB (XDR TB).
|WHO Region||Total||TB Mortality Male 0 - 14 Years||TB Mortality Female 0 - 14 Years||TB Mortality Male > 14 Years||TB Mortality Female > 14 Years|
SA has the means to overcome the TB epidemic situation and the following will have a substantial impact on TB control:
The following chapters are covered in this short course:
This is an online course. Participants have 3 months to complete the assessment process from date of registration.
All healthcare professionals
Accredited according to HCPSA's Medical and Dental Board Guidelines for Healthcare Professionals for 30 Clinical CEU's on Level 2.
Your CPD certificate will be generated to your online CPD Manager, upon completion.
R 1 997.37 (This amount is inclusive of all vat and taxes where applicable)
To access the product, please login or register to continue